1,767 Orion Corporation A shares converted into B shares

19.06.2019 klo 09:30 1,767 Orion Corporation A shares converted into B shares



ORION CORPORATION STOCK EXCHANGE RELEASE 19 JUNE 2019 at 9.30 EEST

1,767 Orion Corporation A shares converted into B shares

In accordance with Section 3 of the Articles of Association of Orion
Corporation, 1,767 A shares have been converted into 1,767 B shares. The
conversion has been entered into the Trade Register on 19 June 2019.

The total number of shares in Orion Corporation is 141,257,828 which, after the
conversion, consists of 36,821,579 A shares and 104,436,249 B shares. The number
of votes of the company's shares is after the conversion 840,867,829


Orion Corporation



 Jari Karlson   Olli Huotari
 CFO            SVP, Corporate Functions





Contact person:
Tuukka Hirvonen, Investor Relations, tel. +358 010 426 2721


Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
www.orion.fi


Orion is a globally operating Finnish pharmaceutical company - a builder of
well-being. Orion develops, manufactures and markets human and veterinary
pharmaceuticals and active pharmaceutical ingredients. The company is
continuously developing new drugs and treatment methods. The core therapy areas
of Orion's pharmaceutical R&D are central nervous system (CNS) disorders,
oncology and respiratory diseases for which Orion develops inhaled Easyhaler®
pulmonary drugs. Orion's net sales in 2018 amounted to EUR 977 million and the
company had about 3,200 employees at the end of the year. Orion's A and B shares
are listed on Nasdaq Helsinki.



This announcement is distributed by West Corporation on behalf of West Corporation
clients.
The issuer of this announcement warrants that they are solely responsible for the content,
accuracy and originality of the information contained therein.

Source: Orion Oyj via GlobeNewswire
http://www.orion.fi
GlobeNewswire